Humana Director Receives 765 Shares in RSU Vesting
HUMANA INC
Subscribe to track HUM
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Humana Director Receives 765 Shares in RSU Vesting
Company: HUMANA INC (HUM) Form: 4 | Filed: 2025-11-04 Significance: Low
Insider: Smith Gordon Title: null | Relationship: Director
Transaction: • Type: Exercise • Shares: 765 • Price: $0.00 • Value: $0 • Owned After: 765
Key Insight: This is a routine, non-market transaction representing the vesting of Restricted Stock Units (RSUs) as part of the director's compensation. It has no market value and is not an indicator of insider sentiment.
Market Context: The transaction represents a negligible 0.0006% of shares outstanding for the $33.46B healthcare company.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: HUMANA INC (HUM)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A director received shares from the vesting of Restricted Stock Units (RSUs) as part of a standard compensation plan.
- Market Impact: Neutral. This is a routine, non-discretionary transaction with no market-moving implications.
Company Information
| Field | Value |
|---|---|
| Company | HUMANA INC |
| Ticker Symbol | HUM |
| CIK | 0000049071 |
| Industry | HOSPITAL & MEDICAL SERVICE PLANS |
Insider Information
| Field | Value |
|---|---|
| Name | Smith Gordon |
| CIK | 0001311487 |
| Title/Position | null |
| Relationship | Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-11-01 |
| Transaction Code | M (Exercise or conversion of derivative security) |
| Security Type | Humana Common |
| Shares Involved | 765 |
| Price Per Share | $0.00 |
| Total Value | $0 |
| Shares Owned After | 765 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $0 |
| % of Market Cap | 0.0% |
| Shares Transacted | 765 |
| % of Shares Outstanding | 0.0006% |
| Post-Transaction Ownership | 765 shares (0.0006% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The transaction has zero monetary value and involves a negligible number of shares relative to Humana's $33.46 billion market capitalization.
- Ownership Concentration: The insider's resulting ownership is extremely small, representing less than 0.001% of total shares outstanding.
- Dilution Impact: The issuance of 765 shares has a virtually non-existent dilutive effect (0.0006%) on existing shareholders.
- Transaction Significance: The transaction is classified as low significance. It is a pre-planned, non-market event related to director compensation, as detailed in the filing's footnotes, and does not reflect a discretionary investment decision.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The transaction is a routine vesting of RSUs, not an open-market purchase or sale. It provides no new information about the company's prospects or the insider's sentiment.
Volume & Sentiment
- Expected Volume Impact: None. This was not an open-market transaction and will not affect trading volume.
- Sentiment Indicator: Neutral. This is a standard compensation event, not a bullish or bearish signal.
Additional Context
Transaction Notes
- Special Circumstances: The filing's footnotes confirm this transaction is related to the director's annual fee, paid in stock units that convert to common stock. This is exempt under Rule 16(b)-3(d)(1).
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
